• Cleveland Cancer Misdiagnosis Lawyer: Nearly Half of All Vascular Events, Infections, or Cancer Misdiagnoses Result in Permanent Disability or Death

    Posted on July 20th, 2020 admin No comments

    These are shocking figures to most, but unsurprising to any cancer misdiagnosis lawyer in Cleveland. Nearly 10% of patients in the United States with symptoms caused by major vascular events, infections, or cancers actually are misdiagnosed, according to a recent Johns Hopkins School of Medicine–led study published in the journal Diagnosis.

    What’s more, nearly one-half, or 53.9%, of those misdiagnosed suffer a permanent disability or die because of the error. Plus, nearly 3/4 of all serious misdiagnosis-related harms in malpractice claims stem from those three areas – major vascular events, infections, or cancer.

    The data is clear: Cancer misdiagnosis is surprisingly common and can be very deadly or debilitating.

    Details of the Study

    Researchers aggregated rates for the 15 diseases from 28 published studies involving 91,755 patients. Among other types of misdiagnosis, the study looked at five key cancers, including lung cancer, breast cancer, colorectal cancer, prostate cancer, and melanoma.

    The study noted:

    “Diagnostic improvement initiatives should focus on dangerous conditions with higher diagnostic error and misdiagnosis-related harm rates.

    “Finally, it is worth pointing out that diseases historically receiving the most sustained attention to diagnosis (i.e. research funding, clinical quality improvement, public awareness) are the ones with the lowest harm rates. Myocardial infarction is the prototype and the only acute illness approaching the target “standard” of <1% harmed often cited in the emergency department. This is, of course, after a half century of focused efforts to automate electrocardiogram interpretation, develop and refine biomarkers (e.g. troponin) and create routine diagnostic protocols for chest pain or suspected acute coronary syndromes. Similarly, basic research studies and clinical trials focused on prostate cancer biomarkers (e.g. prostate-specific antigen) date back to the 1960s. Achieving similar gains may be possible for other key diseases, but only if we make sustained investments in improving diagnosis (e.g., missed stroke in acute dizziness, where novel bedside tests and tele-medicine have shown early promise).”

    Cancer misdiagnosis is a serious and often overlooked issue. If you know of someone who has had a cancer misdiagnosis, contact one of our cancer misdiagnosis lawyers in Cleveland for a free consultation.

     

    Comments are closed.